IP Verse

Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer - EP3254695

PATENT ANALYSIS

Patent Details

Grant Date
Sep 9, 2020
Company
ASTELLAS PHARMA INC.
Oppositions

DR. H. ULRICH DORRIES

More patents of Astellas Pharma Inc.

EP3318259

EP3725810

EP3725778

Want to monitor this patent?

Feel free to send us a message here and we will get back to you